These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5805428)

  • 21. Differentiation of human IgM subclasses by the ability to interact with a factor resembling the first component of complement.
    Mackenzie MR; Warner NL; Linscott WD; Fudenberg HH
    J Immunol; 1969 Sep; 103(3):607-12. PubMed ID: 4979781
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of guinea pig complement component C9: reaction kinetics and evidence that lysis of EAC1-8 results from a single membrane lesion caused by one molecule of C9.
    Rommel FA; Mayer MM
    J Immunol; 1973 Mar; 110(3):637-47. PubMed ID: 4688916
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of anti-macrophage sera on the in vivo synthesis of guinea pig complement components.
    Füst G; Surján M
    Boll Ist Sieroter Milan; 1971; 50(6):488-94. PubMed ID: 5164108
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-immunoglobulin control of immune hemolysis.
    Romeyn JA; Ross S
    J Immunol; 1969 May; 102(5):1242-9. PubMed ID: 5770441
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune hemolysis: serial studies of the dissociability of IgG and IgM anti-Forssman antibodies using the C'la fixation and transfer technique.
    Linscott WD
    J Immunol; 1969 Apr; 102(4):986-92. PubMed ID: 5768199
    [No Abstract]   [Full Text] [Related]  

  • 26. Ca++-dependent binding of antigen-19 S antibody complexes to macrophages.
    Lay WH; Nussenzweig V
    J Immunol; 1969 May; 102(5):1172-8. PubMed ID: 5814168
    [No Abstract]   [Full Text] [Related]  

  • 27. Passive immune lysis with chromic chloride-treated erythrocytes.
    Perucca PJ; Faulk WP; Fudenberg HH
    J Immunol; 1969 Apr; 102(4):812-20. PubMed ID: 5768191
    [No Abstract]   [Full Text] [Related]  

  • 28. Persistence of complement-fixing antibodies in guinea pig sera serially collected in large volumes.
    Gamble WC; Chappell WA; George EH
    Lab Anim Sci; 1974 Aug; 24(4):605-9. PubMed ID: 4369001
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes.
    Atkinson JP; Schreiber AD; Frank MM
    J Clin Invest; 1973 Jun; 52(6):1509-17. PubMed ID: 4703235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic relationships between the first component (Cl) of human and guinea pig complement.
    Colten HR; Borsos T; Rapp HJ
    J Immunol; 1970 May; 104(5):1048-51. PubMed ID: 5309842
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies of the mechanism of binding of chemically modified cytophilic antibodies to macrophages.
    Thrasher SG; Cohen S
    J Immunol; 1971 Sep; 107(3):672-7. PubMed ID: 5572090
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the immune adherence of white blood cells].
    Sachs V
    Bibl Haematol; 1967; 27():91-4. PubMed ID: 5627948
    [No Abstract]   [Full Text] [Related]  

  • 33. Complement and heterophile shock.
    Spear GS; Kihara I
    Johns Hopkins Med J; 1970 Apr; 126(4):210-6. PubMed ID: 5310147
    [No Abstract]   [Full Text] [Related]  

  • 34. Complement: heterogeneity of binding of the first component of complement as a function of antibody concentration.
    Linscott WD
    J Immunol; 1969 May; 102(5):1322-6. PubMed ID: 5770445
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of specific antibodies on the metabolism of guinea pig polymorphonuclear leukocytes.
    Rossi F; Zatti M; Patriarca P; Cramer R
    J Reticuloendothel Soc; 1971 Jan; 9(1):67-85. PubMed ID: 4395618
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of Cu-chlorophyllin on the active site formation of each component of guinea-pig complement.
    Okada H; Nishioka K; Sindo T
    Immunology; 1969 Apr; 16(4):473-80. PubMed ID: 5770389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigations of the complement-fixing sites of immunoglobulins.
    Johnson BJ; Thames KE
    J Immunol; 1976 Nov; 117(5 Pt 1):1491-4. PubMed ID: 1002987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement: chemical coupling of a functionally active component to erythrocytes in the absence of antibody.
    Linscott WD; Faulk WP; Perucca PJ
    J Immunol; 1969 Sep; 103(3):474-9. PubMed ID: 5817169
    [No Abstract]   [Full Text] [Related]  

  • 39. A new immunochemical assay for the detection of the first component of complement C1.
    Colten HR; Spalter JS
    J Immunol; 1970 May; 104(5):1043-7. PubMed ID: 5444335
    [No Abstract]   [Full Text] [Related]  

  • 40. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.